“Having access to such experienced and high profile professionals has had a huge impact on my project. Their advice sharpened my business plan significantly and led to progression in the negotiations with VCs, they introduced me to opportunities (both strategic and financial) which I was not aware of, and through their network, I have received important high-profile legal advice (pro-bono). Furthermore, I was invited to contact them on an ongoing basis which equipped me with an essential understanding of the pivotal points in VC investment terms seen from a founder’s perspective.”
Alexander Hovard Sparre-Ulrich, CEO Antag
Antag (Denmark) is working on a promising hormone treatment to fight obesity.
Hedia (Denmark) is a personal diabetes-assistant
Immunitrack (Denmark) works in the field of immunological molecules such as: the neonatal Fc receptor FcRn and major histocompability molecules (MHC).
Lexplore (Sweden) offers a completely new method for dyslexia screening, enabling early, rapid, reliable and objective identification of children in risk of dyslexia.
MedTrace (Denmark) has developed several novel safety features, which combined will revolutionize blood flow imaging in PET.
MonTa Biosciences (Denmark) is a start-up biotech Company in the cancer immunotherapy field.
Orthogenics (Norway) is leading in the field of joint replacement diagnostics
ChildTreat (Denmark) has deveolped an innovative pain treatment method for children.
SAGA Diagnostics (Sweden) is a personalized cancer medicine and disease monitoring company.
PanCryos (Denmark) aims to develop a next generation stem cell derived allogenic cell therapy (PanINSULA™) for Type 1 diabetes